نتایج جستجو برای: β interferon β

تعداد نتایج: 243008  

2014
Mohammad Hossein Morowvat Valiollah Babaeipour Hamid Rajabi-Memari Hossein Vahidi Nader Maghsoudi

Human Interferon β (INF-β) is a member of cytokines family which different studies have shown its immunomodulatory and antiviral activities. In this study an expression vector was designed and constructed for expression of human INF-β-1b either in shake flasks or bench top bioreactor. The designed vector was constructed based upon pET-25b(+) with T7 promoter. Recombinant human beta interferon (...

Journal: :Molecular Medicine 1997

2015
Rainel Sánchez-de la Rosa Laura García-Bujalance José Meca-Lallana

OBJECTIVE The Escala Study evidenced that the administration of glatiramer acetate for relapsing-remitting multiple sclerosis improved the spasticity of patients previously treated with interferon-β. However, whether such an improvement was translated into cost savings remained unclear. We therefore conducted a cost analysis of glatiramer acetate versus interferon-β in these patients with multi...

Journal: :Journal of Immunology 2023

Abstract Red blood cell (RBC) transfusion can induce anti-RBC antibodies that promote hemolytic events. Patients with systemic lupus erythematosus (SLE) have an increased frequency of RBC alloimmunization, and two-thirds patients express a type 1 interferon (IFNα/β) gene signature. We previously reported IFNα/β induces alloimmunization in the IFNα/β-dependent pristane mouse model. However, it i...

Journal: :modares journal of medical sciences: pathobiology 2007
maryam bikhof torbati hossein khanahmad fatemeh jamshidi morteza karimipour majid sadeghizadeh

objective: β-thalassemia is caused by absence or reduction of β-globin chain synthesis. one of the effective therapeutic methods for this disease can be gene therapy by viral vectors. the capacity of lentiviral vectors is approximately 8 kb, we designed a 6 kb construct containing mini lcr and β-globin gene instead of lcr region. the aim of this study is to make a recombinant lentiviruses conta...

2013
Alireza Minagar

With the introduction of interferon- β 1b in 1993 as the first FDA-approved treatment for multiple sclerosis, the era of treatment of this incurable disease began, and its natural course was permanently changed. Currently, seven different treatments for patients with multiple sclerosis with different mechanisms of action and dissimilar side effect profiles exist. These medications include inter...

2017
Chenyang Yi Zongzheng Zhao Shengyu Wang Xin Sun Dan Zhang Xiaomei Sun Anding Zhang Meilin Jin

The influenza A virus (IAV) can be recognized by retinoic acid-inducible gene I (RIG-I) to activate the type I interferon response and induce antiviral effects. The virus has evolved several strategies to evade the innate immune response, including non-structural protein 1 (NS1) and its polymerase subunits. The mechanism by which NS1 inhibits interferon-β (IFN-β) is well understood, whereas the...

ژورنال: :مجله دانشکده پزشکی اصفهان 0
نسرین زارع دانشجوی کارشناسی ارشد، گروه ایمونولوژی، دانشکده ی پزشکی و کمیته ی تحقیقات دانشجویی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران سید حمید زرکش اصفهانی دانشیار، گروه ایمونولوژی، دانشکده ی پزشکی و مرکز تحقیقات فیزیولوژی کاربردی، دانشگاه علوم پزشکی اصفهان و گروه بیولوژی، دانشکده ی علوم، دانشگاه اصفهان، اصفهان، ایران وحید شایگان نژاد دانشیار، گروه داخلی اعصاب، دانشکده ی پزشکی و مرکز تحقیقات علوم اعصاب، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران مرجان قراگوزلو استادیار، گروه ایمونولوژی، دانشکده ی پزشکی، دانشگاه علوم پزشکی اصفهان، اصفهان، ایران

مقدمه: اینترفرون بتا (ifn-β یا interferon beta) اولین داروی تأیید شده برای درمان مولتیپل اسکلروز (ms یا multiple sclerosis) است. برخی از بیماران مبتلا به ms تحت درمان با ifn-β در برابر این دارو آنتی بادی ایجاد می کنند. آنتی بادی های ضد ifn-β می توانند کارایی بالینی و فعالیت زیستی آن را کاهش دهند. هدف از این مطالعه، طراحی روش elisa برای اندازه گیری آنتی بادی های سرمی ضد اینترفرون در بیماران مبتل...

Journal: :genetics in the 3rd millennium 0
مرداویژ آل بویه mardavij alebouyeh فریده موسوی farideh mousavi حسین حداد دیلمی hossein haddad پروانه وثوق parvaneh vosough

background: many efforts have been undertaken until now to find an alternative approach to packed red cell tranfusion in major β-thalassemia. augmentation of fetal hemoglobin by hydroxyurea has proved to be less effective in this condition as compared to sickle cell anemia, probably due to molecular heterogeneity of the former disease. hydroxyurea efficacy and its relation to xmn1 polymorphism ...

Journal: :iranian journal of public health 0
n saleh-gohari mr bazrafshani

background: mutations in β -globin gene may result in β-thalassemia major, which is one of the most common genetic dis­or­ders in iran and some other countries. knowing the beta-globin mutation spectrum improves the efficiency of prenatal diagno­sis in the affected fetuses (major β-thalassemia) of heterozygote couples. methods: couples with high hemoglobin a 2 and low mean corpuscular volume we...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید